Harmony Biosciences Llc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$18.5M
Doctors Paid
12,362
Transactions
80,823
2024 Total
$3.8M
Payment Breakdown by Category
Research$12.3M (66.4%)
Food & Beverage$1.7M (9.2%)
Consulting$1.0M (5.6%)
Travel$300,332 (1.6%)
Royalty/License$27,000 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.3M | 2,286 | 66.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.7M | 1,354 | 14.4% |
| Food and Beverage | $1.7M | 72,307 | 9.2% |
| Consulting Fee | $1.0M | 969 | 5.6% |
| Travel and Lodging | $300,332 | 1,017 | 1.6% |
| Education | $218,265 | 2,802 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $197,356 | 81 | 1.1% |
| Grant | $67,391 | 4 | 0.4% |
| Royalty or License | $27,000 | 1 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $8,000 | 2 | 0.0% |
Payments by Type
Research
$12.3M
2,286 transactions
General
$6.2M
78,537 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension | $4.1M | 1 | 340 |
| A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia | $3.7M | 7 | 618 |
| An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients With Idiopathic Hypersomnia Who Completed Study HBS-101-CL-010 | $2.1M | 5 | 860 |
| Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 | $1.3M | 0 | 247 |
| A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome | $435,256 | 0 | 119 |
| HBS-101-CL-001 | $207,984 | 4 | 57 |
| An Open-Label, Long-Term Safety Study to Evaluate the Safety and Tolerability of Pitolisant in Pediatric Patients with Prader Willi Syndrome (PWS) who Participated in Study HBS 101 CL 003 | $198,534 | 0 | 19 |
| An Open-Label, Long-Term Safety Study to Evaluate the Safety and Tolerability of Pitolisant in Pediatric Patients with Prader-Willi Syndrome (PWS) who Participated in Study HBS-101-CL-003 | $125,819 | 0 | 12 |
| WAKIX (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring | $14,925 | 5 | 14 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Haramandeep Singh, Md, MD | Sleep Medicine | San Ramon, CA | $488,697 | $0 |
| William Winter, Md, MD | Neurology | Charlottesville, VA | $318,738 | $0 |
| Dr. Abhinav Singh, Md, MD | Sleep Medicine | Greenwood, IN | $236,232 | $0 |
| Peter Ottavio, D.o, D.O | Internal Medicine | Port Jefferson Station, NY | $209,854 | $0 |
| Dr. James Roy, M.d., Ph.d, M.D., PH.D | Internal Medicine | Huntsville, AL | $199,563 | $0 |
| Gerard Meskill, Md, MD | Neurology | Sugar Land, TX | $145,967 | $0 |
| Dr. Steven Gradney, M.d, M.D | Internal Medicine | Springfield, MO | $121,195 | $0 |
| Ellen Wermter, Np, NP | Family | Charlottesville, VA | $112,870 | $0 |
| Matthew Davis, Md, MD | Sleep Medicine | Middletown, NJ | $102,448 | $0 |
| Dr. William Burkes, M.d, M.D | Internal Medicine | Beaumont, TX | $95,310 | $0 |
| Dr. Kenneth Halliwell, M.d, M.D | Sleep Medicine | Williamsville, NY | $90,939 | $0 |
| Lewis Kass, Md, MD | Pediatric Pulmonology | Philadelphia, PA | $86,321 | $0 |
| Dr. Helene Emsellem, Md, MD | Neurology | Potomac, MD | $84,372 | $0 |
| Dr. Margaret Park, Md, MD | Sleep Medicine | Chicago, IL | $80,514 | $0 |
| Dr. Alcibiades Rodriguez, Md, MD | Neurology | New York, NY | $79,167 | $0 |
| Dr. Jeremy Mcconnell, M.d, M.D | Family Medicine | Bradenton, FL | $78,069 | $0 |
| Dr. Richard Bogan, M.d, M.D | Pulmonary Disease | Columbia, SC | $77,290 | $0 |
| Dr. Omavi Bailey, Md Mph, MD MPH | Sleep Medicine | Fayetteville, NC | $76,129 | $0 |
| Dr. Asim Roy, M.d, M.D | Sleep Medicine | Dublin, OH | $73,662 | $0 |
| Debra Stultz, M.d, M.D | Psychiatry | Barboursville, WV | $69,341 | $0 |
| Dr. Edward Mezerhane, Md, MD | Internal Medicine | Miami, FL | $66,264 | $0 |
| Dr. Jonathan Lown, Md, MD | Sleep Medicine | Commack, NY | $56,949 | $0 |
| Dr. Sujit Varma, Md, MD | Psychiatry | Edina, MN | $55,539 | $0 |
| Michael Ledet, Md, MD | Sleep Medicine | Daphne, AL | $53,197 | $0 |
| Kirsten Bracht, Md, MD | Specialist | Englewood, CO | $52,783 | $0 |
About Harmony Biosciences Llc
Harmony Biosciences Llc has made $18.5M in payments to 12,362 healthcare providers, recorded across 80,823 transactions in the CMS Open Payments database. In 2024, the company paid $3.8M. The top product by payment volume is WAKIX ($5.3M).
Payments were distributed across 172 medical specialties. The top specialty by payment amount is Sleep Medicine ($1.7M to 572 doctors).
Payment categories include: Food & Beverage ($1.7M), Consulting ($1.0M), Research ($12.3M), Travel & Lodging ($300,332), Royalties ($27,000).
Harmony Biosciences Llc is associated with 2 products in the CMS Open Payments database.